APA (7th ed.) Citation

K, S., T, M., S, T., L, I., T, N., K, T., . . . K, F. (2025). Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy. Anticancer research, 45(8), 3355. https://doi.org/10.21873/anticanres.17696

Chicago Style (17th ed.) Citation

K, Sugimoto, et al. "Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy." Anticancer Research 45, no. 8 (2025): 3355. https://doi.org/10.21873/anticanres.17696.

MLA (9th ed.) Citation

K, Sugimoto, et al. "Rash and Endocrine Disorders Predict Improved Survival in Metastatic Renal Cell Carcinoma Treated With Immunotherapy." Anticancer Research, vol. 45, no. 8, 2025, p. 3355, https://doi.org/10.21873/anticanres.17696.